At week 52, using the treatment-policy estimand analysis, however, the oral semaglutide group experienced significantly greater decreases in A1C compared with both the liraglutide and placebo groups
Useful for discussing your schedule with a provider or comparing weekly vs
Educational Display Only This product information is for educational purposes
Weight loss Weight loss with GLP-1 treatment usually moves at a slower pace to start
Glucagon-like peptide-1 (GLP-1) is a naturally occurring hormone that plays a vital role in regulating blood glucose, appetite, and metabolic health
In the SURMOUNT 1 trial, tirzepatide at doses of 5 mg, 10 mg and 15 mg were evaluated against placebo, with pooled tirzepatide groups resulting in significant decreases in total cholesterol, LDL-C, VLDL-C, FFA, and triglycerides and an increase in HDL-C at week 72 of follow-up [35]